NO20080002L - Formuleringer av konjugerte ostrogener og bazedoxifen - Google Patents

Formuleringer av konjugerte ostrogener og bazedoxifen

Info

Publication number
NO20080002L
NO20080002L NO20080002A NO20080002A NO20080002L NO 20080002 L NO20080002 L NO 20080002L NO 20080002 A NO20080002 A NO 20080002A NO 20080002 A NO20080002 A NO 20080002A NO 20080002 L NO20080002 L NO 20080002L
Authority
NO
Norway
Prior art keywords
bazedoxifene
conjugated estrogens
formulations
salt
estrogens
Prior art date
Application number
NO20080002A
Other languages
English (en)
Inventor
Arwinder Nagi
Ramarao S Chatlapalli
Lawrence Van Pelt
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37401610&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20080002(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20080002L publication Critical patent/NO20080002L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Det beskrives faste doseringsformuleringer som inneholder konjugerte østrogener og bazedoxifen eller et salt derav. I enkelte utførelsesformer inkluderer blandingene en kjerne som omfatter konjugerte østrogener og minst ett overtrekk som omfatter bazedoxifen eller et salt derav.
NO20080002A 2005-06-29 2008-01-02 Formuleringer av konjugerte ostrogener og bazedoxifen NO20080002L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69488905P 2005-06-29 2005-06-29
PCT/US2006/025348 WO2007002823A2 (en) 2005-06-29 2006-06-28 Formulations of conjugated estrogens and bazedoxifene

Publications (1)

Publication Number Publication Date
NO20080002L true NO20080002L (no) 2008-03-12

Family

ID=37401610

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20080002A NO20080002L (no) 2005-06-29 2008-01-02 Formuleringer av konjugerte ostrogener og bazedoxifen

Country Status (19)

Country Link
US (1) US20070003623A1 (no)
EP (1) EP1898888A2 (no)
JP (1) JP2008545012A (no)
KR (1) KR20080031037A (no)
CN (1) CN101252921A (no)
AR (1) AR054806A1 (no)
AU (1) AU2006263638A1 (no)
BR (1) BRPI0612586A2 (no)
CA (1) CA2613102A1 (no)
CR (1) CR9597A (no)
EC (1) ECSP078057A (no)
IL (1) IL188223A0 (no)
NI (1) NI200700331A (no)
NO (1) NO20080002L (no)
PA (1) PA8684501A1 (no)
PE (1) PE20070188A1 (no)
RU (1) RU2395286C2 (no)
TW (1) TW200738283A (no)
WO (1) WO2007002823A2 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8629301A1 (es) * 2004-04-08 2006-10-13 Wyeth Corp Formulaciones de acetato de bezedoxifeno
CN101541326A (zh) * 2006-11-29 2009-09-23 惠氏公司 雌激素/选择性雌激素受体调节剂（serm）和雌激素/孕酮双层药片
KR20090104862A (ko) * 2007-01-12 2009-10-06 와이어쓰 정제내 정제 조성물
PE20090100A1 (es) * 2007-03-30 2009-02-26 Wyeth Corp Metodos de separacion y deteccion de acetato de bacedoxifeno en composiciones farmaceuticas
WO2011056532A2 (en) 2009-10-27 2011-05-12 Wyeth Llc Bazedoxifene formulations with antioxidants
BR112012026843A2 (pt) * 2010-04-20 2016-07-12 Cipla Ltd composição, composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição e método para tratamento de hiv
CN103119878B (zh) * 2010-07-29 2016-11-16 熵通信有限公司 用于消除交叉极化干扰和交叉卫星干扰的方法和装置
PH12013502325A1 (en) * 2011-05-13 2014-02-10 Eb Ip Hybritabs B V Drug delivery system
CN104013630B (zh) * 2014-05-23 2018-08-21 合肥九研医药科技开发有限公司 一种复方醋酸巴多昔芬雌激素组合物
NZ737945A (en) 2015-06-18 2023-06-30 Estetra Sprl Orodispersible dosage unit containing an estetrol component
CA3178291A1 (en) 2016-08-05 2018-04-12 Estetra Srl Method for the management of dysmenorrhea and menstrual pain
WO2018182205A1 (ko) * 2017-03-30 2018-10-04 한미약품 주식회사 바제독시펜 아세테이트를 함유하는 안정화된 약제학적 조성물
CR20200486A (es) * 2018-04-19 2021-01-27 Estetra Sprl Compuestos y sus usos para aliviar los síntomas asociados a la menopausa
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
CN114306247B (zh) * 2020-09-27 2026-03-06 江苏先声药业有限公司 一种含利福喷汀药物组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2565115A (en) * 1948-10-28 1951-08-21 Squibb & Sons Inc Method of obtaining a conjugated estrogen preparation
US2720483A (en) * 1951-02-21 1955-10-11 Olin Mathieson Method of obtaining a conjugatedestrogen preparation
US5210081A (en) * 1992-02-26 1993-05-11 American Home Products Corporation Alkali metal 8,9-dehydroestrone sulfate esters
US5759577A (en) * 1995-01-17 1998-06-02 American Home Products Corporation Controlled release of steroids from sugar coatings
US5547948A (en) * 1995-01-17 1996-08-20 American Home Products Corporation Controlled release of steroids from sugar coatings
US5998402A (en) * 1996-04-19 1999-12-07 American Home Products Corporation 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
US6479535B1 (en) * 1998-05-15 2002-11-12 Wyeth 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
DE60043305D1 (de) * 1999-07-06 2009-12-24 Endorech Inc Pharmazeutische zubereitungen zur behandlung von insulinresitenz
AR029538A1 (es) * 2000-07-06 2003-07-02 Wyeth Corp Composiciones farmaceuticas de agentes estrogenicos
SG162615A1 (en) * 2002-06-13 2010-07-29 Wyeth Corp Bazedoxifene treatment regimens
TW200536845A (en) * 2004-04-07 2005-11-16 Wyeth Corp Crystalline polymorph of bazedoxifene acetate
SG151331A1 (en) * 2004-04-07 2009-04-30 Wyeth Corp Crystalline polymorph of a bazedoxifene acetate
BRPI0509385A (pt) * 2004-04-08 2007-09-18 Wyeth Corp composto, composição, métodos de preparar o sal, ea dispensão sólida, de tratar um mamìfero tendo uma doença ou sìndrome associadas com a deficiência de estrogênio ou excesso de estrogênio, uma doença ou distúrbio associados com a proliferação ou desenvolvimento anormal dos tecidos endometriais, de tratar cáncer de mama em um mamìfero, e uma mulher pós-menopáusica quanto a um ou mais distúrbios vasomotores, de reduzir colesterol, e de inibir perda óssea em um mamìfero, dispersão sólida, e, uso de um composto
PA8629301A1 (es) * 2004-04-08 2006-10-13 Wyeth Corp Formulaciones de acetato de bezedoxifeno

Also Published As

Publication number Publication date
WO2007002823A2 (en) 2007-01-04
JP2008545012A (ja) 2008-12-11
US20070003623A1 (en) 2007-01-04
BRPI0612586A2 (pt) 2010-11-23
NI200700331A (es) 2009-02-16
PA8684501A1 (es) 2007-01-17
EP1898888A2 (en) 2008-03-19
WO2007002823A3 (en) 2007-08-09
CR9597A (es) 2008-03-06
KR20080031037A (ko) 2008-04-07
IL188223A0 (en) 2008-03-20
CN101252921A (zh) 2008-08-27
AR054806A1 (es) 2007-07-18
RU2007148071A (ru) 2009-08-10
RU2395286C2 (ru) 2010-07-27
PE20070188A1 (es) 2007-03-16
CA2613102A1 (en) 2007-01-04
AU2006263638A1 (en) 2007-01-04
ECSP078057A (es) 2008-01-23
TW200738283A (en) 2007-10-16

Similar Documents

Publication Publication Date Title
ECSP078057A (es) Formulaciones de estrógenos conjugados y bazedoxifeno
NO20070373L (no) Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
ATE447568T1 (de) Neue pyrinderivate
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
UY31145A1 (es) Derivado de 17b+ciano-18a-homo-19-nor-androst-4-eno, su uso y medicamento que lo contiene
NO20082376L (no) Farmasoytiske sammensetninger
PL379212A1 (pl) Kompozycje bakteriobójcze, sposoby i układy
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
PL410219A1 (pl) Kompozycja zawierająca koniugat leku obejmujący pochodne kalicheamycyny i przeciwciało, oraz kompozycja farmaceutyczna ją zawierająca
IL188050A (en) The history of azaindazole, their medicinal preparations and their uses
BRPI0407373A (pt) Espuma hidro-alcoólica formando espuma em filme
HRP20080297T3 (en) Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
NO20071944L (no) Hydrolysestabil beleggingsmiddelsammensetning
CR8824A (es) Derivados de 2-carbamida-4-feniltiazol, su preparacion y su aplicacion en terapeutica
GT200800107A (es) Formulaciones orales que comprenden tigeciclina
EA200900267A1 (ru) КОМПОЗИЦИЯ ДЛЯ АЭРОЗОЛЬНОЙ ИНГАЛЯЦИИ β-АГОНИСТОВ И СТЕРОИДОВ
EP2153831A4 (en) ANTIERMÜDUNGSMITTEL AND ORAL COMPOSITION, BOTH WITH ANDROGRAPHOLIDE AS ACTIVE INGREDIENTS
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
NO20045385L (no) Farmasoytisk preparat inneholdende okskarbazepin med kontrollert frigivelse av aktivt stoff
MEP34308A (en) Oral formulations of cladribine
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
BRPI0313645A2 (pt) composições de inalação com relações de droga elevadas.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application